🧬 biology

Mitochondrial Macro-Haplogroup U and Multiple Sclerosis Risk in Arab and Near Eastern Populations: A Pedigree-Anchored Systematic Review and Meta-Analysis

This pedigree-anchored systematic review and meta-analysis demonstrates a robust, directionally consistent association between mitochondrial macro-haplogroup U and Multiple Sclerosis risk across Arab, Iranian, and European populations, yielding a pooled odds ratio of 1.91 despite the limited power of the initial Arab discovery cohort.

Original authors: Ibrahim Ibrahim Shuaibu

Published 2026-06-28

📖 5 min read🧠 Deep dive

CC BY 4.0

Original authors: Ibrahim Ibrahim Shuaibu

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Big Picture: A Genetic "Spark Plug" Problem

Imagine your body is a massive city, and your brain is the city's most important power plant. To keep the lights on, this power plant needs a lot of fuel. The "engines" that burn this fuel are called mitochondria.

This study looks at a specific type of engine variation found in many people from the Middle East, Near East, and Europe, called Mitochondrial Haplogroup U. Think of Haplogroup U as a specific model of engine that runs a little "hotter" than the standard model. It produces a bit more exhaust fumes (called Reactive Oxygen Species or ROS) while working.

Usually, this extra exhaust isn't a problem. But in people with Multiple Sclerosis (MS), the brain's power plant is already under attack by the immune system. If you add a "hotter" engine that produces more exhaust to a power plant that is already struggling, the damage gets worse, and the power plant (the brain) fails faster.

The Question

Scientists wanted to know: Does having this "hotter" engine (Haplogroup U) actually make people more likely to get MS?

There was one small study from Saudi Arabia that said, "Yes! It makes the risk 6 times higher!" But that study was very small (only 47 people), and when they checked the math strictly, the result wasn't quite strong enough to be 100% sure.

So, this new paper decided to act like a detective, gathering all the clues from different countries to see if the story holds up.

The Detective Work: How They Did It

The researchers didn't just look at numbers; they looked at family trees.

In many Western countries, family history records can be messy or incomplete. But in Arab and Near Eastern cultures, there is a strong tradition of keeping detailed family trees (called Shajara) that trace mothers back many generations.

The Innovation: The researchers used these ancient family trees as a "quality filter."
- Tier 1 (Gold Standard): Studies that used these detailed family trees to make sure the patients and healthy controls were from the same maternal family lines. These studies got full weight in the final calculation.
- Tier 2 (Silver Standard): Studies that didn't have the family trees but matched people by location. These studies got slightly less weight (70%) because there was a tiny chance of mixing up different family groups.

They combined data from three studies:

Saudi Arabia: The small, original study.
Poland: A larger study of European patients.
Iran: A study of Persian patients.

What They Found

When they put all the pieces of the puzzle together, the answer was clear: Yes, there is a link.

The Result: People with Haplogroup U are about 1.9 times more likely to have MS than people without it.
The Consistency: Even though the Saudi study was small and had a huge number (6.26), the larger studies from Poland and Iran showed a similar, though more moderate, increase in risk (around 1.7 to 1.9).
The Proof: When the researchers removed the small Saudi study from the math to see if it was "cheating" the results, the link still existed. This means the finding isn't just a fluke from one small group; it's a real pattern seen across different cultures.

Why This Matters (According to the Paper)

The paper makes a few key points about what this means:

It's a "Directional" Signal: The study confirms that the "hotter engine" (Haplogroup U) is consistently pointing toward higher MS risk across Arab, Iranian, and European populations.
The Saudi Study Was Just the Start: The original Saudi study was too small to be the final word on its own, but it correctly guessed the direction of the problem.
Family Trees are a Superpower: The paper argues that using traditional Islamic family records (Shajara) is a brilliant way to solve a common problem in genetics: making sure you aren't comparing apples to oranges. This method could be used for future research.

What the Paper Does NOT Say

It does not say this is a cure.
It does not say everyone with Haplogroup U will get MS. (Most people with this engine type are fine; it just increases the risk slightly).
It does not say this is the only cause. MS is complex, and this is just one piece of the puzzle.

The Bottom Line

Think of MS risk like a car driving on a rough road.

The Road: The immune system attack (the rough road).
The Car: Your brain cells.
Haplogroup U: A slightly less efficient engine.

This study proves that if you have the "less efficient engine" (Haplogroup U), your car is more likely to break down when the road gets rough. The researchers used family trees to make sure they were comparing the right cars, and they found that this engine issue is a real, consistent risk factor for people in the Middle East and Europe.

The Next Step: The authors say we need a much bigger study (with over 500 patients) using these family trees to get the exact numbers right, but the direction of the discovery is now solid.

Technical Summary: Mitochondrial Macro-Haplogroup U and Multiple Sclerosis Risk in Arab and Near Eastern Populations

Problem Statement
Multiple Sclerosis (MS) is an inflammatory neurodegenerative disease where the HLA-DRB1 locus explains only a portion of heritability, leaving the remaining genetic architecture incompletely characterized. Given the central nervous system's high energetic demand and dependence on mitochondrial integrity, mitochondrial DNA (mtDNA) variants are hypothesized risk factors. Specifically, mitochondrial macro-haplogroup U, prevalent in Middle Eastern and Near Eastern populations, encodes variants in NADH dehydrogenase subunits associated with elevated Reactive Oxygen Species (ROS) production. While a 2022 study (Al-Kafaji et al.) reported a strong association between haplogroup U and Relapsing-Remitting MS (RRMS) in Saudi Arab patients, the finding was based on a small sample size (n=47) and did not survive Bonferroni correction. There is a lack of robust, cross-population validation to determine if this signal is a genuine risk factor or a statistical artifact, particularly within Arab populations where consanguinity and nuclear population stratification complicate genetic association studies.

Methodology
This study employs a PRISMA 2020 systematic review and meta-analysis framework to evaluate the association between mtDNA haplogroup U and MS risk across Arab, Near Eastern, and European populations.

Search Strategy: A search of PubMed/MEDLINE was conducted up to March 1, 2025, targeting studies comparing mtDNA haplogroup frequencies in MS cases versus matched controls in the specified regions.
Pedigree-Anchored Quality Framework: A novel methodological filter was applied to address the challenge of nuclear population stratification in consanguineous populations.
- Tier 1 (Full Weight): Studies documenting maternal lineage records (e.g., Islamic Shajara genealogical records or equivalent) to ensure case-control matching on maternal lineage.
- Tier 2 (70% Weight): Studies without specific maternal lineage documentation but with geographically matched controls.
Statistical Analysis: Odds Ratios (ORs) were pooled using a DerSimonian-Laird random-effects model. Sensitivity analyses included a "leave-one-out" approach excluding the high-leverage Arab discovery cohort. Heterogeneity was assessed via $I^2$ statistics, and publication bias was evaluated using Egger's test.

Key Contributions

Cross-Population Validation: The study aggregates data from three studies (total n=565; 127 cases, 438 controls) including Saudi Arab, Polish, and Iranian cohorts to test the directional consistency of the haplogroup U signal.
Methodological Innovation: The paper introduces a "pedigree-anchored" quality framework that leverages Islamic genealogical traditions (Shajara and Nisba) as a control mechanism for maternal lineage matching. This transforms the challenge of consanguinity in Middle Eastern genomic research into a unique advantage for mtDNA association studies, effectively eliminating nuclear population stratification noise.
Robustness Testing: By explicitly down-weighting studies lacking lineage documentation and performing sensitivity analyses, the study isolates the signal from the limitations of the original small-scale discovery study.

Results

Pooled Association: The meta-analysis yielded a pooled Odds Ratio (OR) of 1.91 (95% CI 1.34–2.72; p = 0.003), indicating a statistically significant association between haplogroup U (or J/U lineages) and MS risk across all included populations.
Individual Study Findings:
- Al-Kafaji et al. (2022): Saudi cohort (n=47) showed a high point estimate (OR 6.26) but wide confidence intervals (1.18–33.14), consistent with a small, hypothesis-generating sample.
- Kowalska et al. (2016): Polish cohort (n=310) showed OR 1.72 (95% CI 1.08–2.74).
- Andalib et al. (2013): Iranian cohort (n=208) showed OR 1.95 (95% CI 1.10–3.46) for J/U lineages.
Sensitivity Analysis: Excluding the small Arab discovery cohort resulted in a pooled OR of 1.82 (95% CI 1.22–2.71; p = 0.003), confirming that the significant signal is not driven solely by the high-leverage, small-sample study.
Heterogeneity: Moderate-to-high heterogeneity was observed ( $I^2$ =66%), primarily driven by the wide confidence interval of the small Arab discovery cohort compared to the more precise validation cohorts. No significant publication bias was detected.

Significance and Claims
The paper claims that mitochondrial haplogroup U is directionally and statistically associated with MS risk across Arab, Iranian, and European populations. However, the authors maintain a modest stance regarding the Arab-specific data:

The original Arab discovery study is acknowledged as underpowered for definitive conclusions; its high OR is interpreted as a hypothesis-generating signal rather than a precise effect estimate.
The study does not claim to have overcome the multiple testing limitations of the single original study but rather provides the cross-population context to validate the direction of the effect.
The primary significance lies in the pedigree-anchoring methodology, which offers a replicable framework for future mtDNA research in the Middle East by utilizing genealogical records to control for stratification.
The authors conclude that a prospective, adequately powered (n > 500), pedigree-anchored study in Arab MS cohorts is the necessary next step to definitively characterize this risk factor.